CD45RA depleted donor lymphocyte infusion (DLI)

BIOLOGICAL2 trials

Sponsors

University Hospital Tuebingen, Ruijin Hospital

Conditions

Haplo-identical HCTHematologic Malignancy

Phase 1

CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT

RecruitingNCT05943067

University Hospital TuebingenHematologic Malignancy

Start: 2023-04-27End: 2028-12-31Target: 60Updated: 2025-04-27

CD45RA-depleted DLI for the Treatment of Refractory/Persistent Viral Infections After Haploidentical Transplantation

RecruitingNCT07662369

Ruijin HospitalHaplo-identical HCT, Hematologic Malignancy

Start: 2026-06-01End: 2028-06-30Target: 30Updated: 2026-06-23